{{Drugbox
| verifiedrevid = 449587183
| IUPAC_name = 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one
| image = Reclazepam.svg
| width = 202

<!--Clinical data-->
| tradename =  
| legal_status =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 76053-16-2
| ATC_prefix = none
| PubChem = 3052777
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2314554
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = YJL42911RA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05710

<!--Chemical data-->
| C=18 | H=13 | Cl=2 | N=3 | O=2 
| molecular_weight = 374.221 g/mol
| smiles = Clc1ccccc1/C4=N/CCN(C\2=N\C(=O)CO/2)c3ccc(Cl)cc34
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H13Cl2N3O2/c19-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)20)21-7-8-23(15)18-22-16(24)10-25-18/h1-6,9H,7-8,10H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MQGIGGJUPITZSE-UHFFFAOYSA-N
}}

'''Reclazepam'''<ref>US Patent 4208327</ref> is a drug which is a [[benzodiazepine]] derivative. It has [[sedative]] and [[anxiolytic]] effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.<ref>{{cite web |author=Pscyhotropics.dk |title=reclazepam |url=http://www.psychotropics.dk/moleculeView/default.aspx?ID=1442&Catalogtype=A&ChapterID=1&Thissortorder=39 |publisher= |date=20 January 1986 |accessdate=24 August 2009}}</ref>

==See also==
*[[Benzodiazepine]]

==References==
<references/>

{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Oxazolones]]

{{sedative-stub}}